Metadata for the dataset: Impact of the COVID-19 Pandemic on Treatment Interruptions and Survival in Patients with Early Breast Cancer

This is a metadata-only record describing the dataset used in the study “Impact of the COVID-19 Pandemic on Treatment Interruptions and Survival in Patients with Early Breast Cancer”.The underlying individual-level research data are not publicly shared because they contain sensitive health-related personal data and because public disclosure could pose a risk of patient re-identification. The record is made publicly available to provide metadata in accordance with the Regulation on the implementation of scientific research work in accordance with the principles of open science.The study includes patients with pathologically confirmed non-metastatic breast cancer diagnosed in Slovenia between 1 January 2018 and 31 December 2022. The dataset includes clinical, tumour, treatment, SARS-CoV-2 infection, treatment interruption, recurrence, and survival-related variables.本记录仅包含元数据，用于说明研究《新型冠状病毒肺炎（COVID-19）大流行对早期乳腺癌患者治疗中断及生存的影响》所使用的数据集。原始个体层面的研究数据因包含敏感的健康相关个人信息，且公开披露可能引发患者身份被重新识别的风险，故未公开共享。本元数据记录遵循开放科学原则，依据《科研工作实施条例》公开，旨在提供相关元数据支持。本研究纳入2018年1月1日至2022年12月31日期间在斯洛文尼亚确诊的经病理学确认的非转移性乳腺癌患者。数据集涵盖临床、肿瘤、治疗、严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染、治疗中断、复发及生存相关变量。